BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1871558)

  • 1. Prediction of T1-2 GI-II transitional cell bladder cancer; evaluation by histoquantitative methods.
    Lipponen PK; Eskelinen MJ; Sotarauta M
    Scand J Urol Nephrol; 1991; 25(2):129-34. PubMed ID: 1871558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear morphometry in grading transitional cell bladder cancer compared with subjective histological grading.
    Lipponen P; Eskelinen M
    Anticancer Res; 1990; 10(6):1725-30. PubMed ID: 2285249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of superficial bladder cancer by histoquantitative methods.
    Lipponen PK; Eskelinen MJ; Sotarauta M
    Eur J Cancer; 1990; 26(10):1060-3. PubMed ID: 2148881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer.
    Lipponen PK; Eskelinen MJ; Kiviranta J; Nordling S
    Anticancer Res; 1991; 11(2):911-6. PubMed ID: 2064350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction.
    Lipponen PK; Eskelinen MJ; Kiviranta J; Pesonen E
    J Urol; 1991 Dec; 146(6):1535-40. PubMed ID: 1942335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent clinical, histological and quantitative prognostic factors in transitional-cell bladder tumours, with special reference to mitotic frequency.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
    Int J Cancer; 1992 May; 51(3):396-403. PubMed ID: 1592531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volume-corrected mitotic index and mitotic activity index in transitional cell bladder cancer.
    Lipponen PK; Eskelinen MJ
    Eur Urol; 1990; 18(4):258-62. PubMed ID: 2289518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume corrected mitotic index (M/V index) in human bladder cancer; relation to histological grade (WHO), clinical stage (UICC) and prognosis.
    Lipponen PK; Collan Y; Eskelinen MJ; Pesonen E; Sotarauta M
    Scand J Urol Nephrol; 1990; 24(1):39-45. PubMed ID: 2320971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma.
    Eskelinen M; Lipponen P; Aitto-Oja L; Hall O; Syrjänen K
    Int J Cancer; 1993 Oct; 55(4):547-54. PubMed ID: 8406980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in nodular transitional cell bladder tumours.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
    Scand J Urol Nephrol; 1993; 27(2):205-10. PubMed ID: 8351473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation indices as independent prognostic factors in papillary Ta-T1 transitional cell bladder tumours.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Terho R; Nordling S
    Br J Urol; 1993 Oct; 72(4):451-7. PubMed ID: 8261303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent prognostic factors in T2/T3 transitional cell bladder tumours with special reference to histoquantitative methods.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Terho R; Nordling S
    Surg Oncol; 1992 Apr; 1(2):135-43. PubMed ID: 1341244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of superficial bladder cancer by nuclear image analysis.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
    Eur J Cancer; 1992; 29A(1):61-5. PubMed ID: 1445747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grading of superficial bladder cancer by quantitative mitotic frequency analysis.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
    J Urol; 1993 Jan; 149(1):36-41. PubMed ID: 8417213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R
    Eur J Cancer; 1992; 29A(1):69-75. PubMed ID: 1445749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereologically measured nuclear volume in comparison to two-dimensional nuclear morphometry, mitotic index and flow cytometry in predicting disease outcome in bladder cancer.
    Lipponen PK
    Anticancer Res; 1993; 13(2):529-32. PubMed ID: 8517668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis.
    Lipponen PK; Aaltomaa S
    J Pathol; 1994 Aug; 173(4):333-9. PubMed ID: 7965393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to count mitoses in bladder cancer grading?
    Lipponen PK; Eskelinen MJ
    Anticancer Res; 1991; 11(2):825-9. PubMed ID: 2064337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of morphometry and DNA flow cytometry with standard prognostic factors in bladder cancer.
    Lipponen PK; Collan Y; Eskelinen MJ; Pesonen E; Sotarauta M; Nordling S
    Br J Urol; 1990 Jun; 65(6):589-97. PubMed ID: 2372672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic correlation of morphometric values with survival in invasive transitional cell carcinoma of the bladder.
    Portillo JA; Val-Bernal JF; Garijo MF; Buelta L; Gutiérrez JL
    Br J Urol; 1992 Dec; 70(6):628-33. PubMed ID: 1486389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.